Enhancing liver blood flow after cardiopulmonary bypass: The effects of dopamine and dopexamine

Perfusion

Volumn 14, Issue 1, 1999, Pages 29-36

  Sharpe, D A C ^a   Mitchel, I M ^a   Kay, E A ^a   McGoldrick, J P ^a   Munsch, C M ^a   Kay, P H ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPEXAMINE; INDOCYANINE GREEN;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD FLOWMETRY; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DENSITOMETRY; DRUG INFUSION; FEMALE; HEART INDEX; HEART OUTPUT; HEART RATE VARIABILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER BLOOD FLOW; MALE; MEDICAL INSTRUMENTATION; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

EID: 0032910299     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919901400105     Document Type: Article

References (50)

1. Bynum TE, Boitnott JK, Maddrey WC. Ischaemic hepatitis. Dig Dis Sci 1979; 24: 129-35.
2. Sherlock S. The liver in heart failure. Relation of anatomical, functional and circulatory changes. Br Heart J 1951; 13: 273-93.
3. Ware JA. The liver when the heart fails. Gastroentrology 1978; 74: 627-28.
4. Olsson R, Hermodsson S, Roberts D, Waldenstrom J. Hepatic dysfunction after open-heart surgery. Scand J Thorac Cardiovasc Surg 1984; 18: 217-22.
5. Robinson JS, Cole FR, Gibson P, Simpson JA. Jaundice following cardiopulmonary bypass. Thorax 1967; 22: 232-37.
6. Sanderson RG, Ellison JH, Benson JA, Starr A. Jaundice following open-heart surgery. Ann Surg 1967; 165: 217-24.
7. Hill DM, Warren SE, Mitas JA, Swerdlin AHR. Hepatic coma after open heart surgery. South Med J 1980; 73: 906-11.
8. Collins JD, Bassendine MF, Ferner R et al. Incidence and prognostic importance of jaundice after cardiopulmonary bypass surgery. Lancet 1983; 1: 1119-23.
9. Chu C-M, Chang C-H, Liaw Y-F, Hsieh M-J. Jaundice after open heart surgery: a prospective study. Thorax 1984; 39: 52-56.
10. Mundth ED, Keller AR, Austen WG. Progressive hepatic and renal failure associated with low cardiac output following open-heart surgery. J Thorac Cardiovasc Surg 1967; 53: 275-84.
11. Jenkins JG, Lynn AM, Wood AE, Trusler GA, Barker GA. Acute hepatic failure following cardiac operation in children. J Thorac Cardiovasc Surg 1982; 84: 865-71.
12. Hampton WW, Townsend MC, Schirmer WJ, Haybron DM, Fry DE. Effective hepatic blood flow during cardiopulmonary bypass. Arch Surg 1989; 124: 458-59.
13. Matsuda H, Corvino E, Hirose H et al. Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. Analysis of the contributing factors and its relation to the early prognosis. J Thorac Cardiovasc Surg 1988; 96: 219-26.
14. Lees MH, Herr RH, Hill JD et al. Distribution of systemic blood flow in the rhesus monkey during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1971; 61: 570-86.
15. Rudolph AM, Heymann MA. Measurement of flow in perfused organs, using microsphere techniques. Acta Endocrinol 1972; 158 (suppl): 112-27.
16. Rudy LW Jr, Heymann MA, Edmunds LH Jr. Distribution of systemic blood flow during total cardiopulmonary bypass in rhesus monkeys. Surg Forum 1970; 21: 149-51.
17. Rudy LW Jr, Heymann MA, Edmunds LH Jr. Distribution of systemic blood flow during cardiopulmonary bypass. J Appl Physiol 1973; 34: 194-200.
18. 2-adrenergic receptors. Br J Pharmocol 1985; 58: 599-605.
19. Lokhandwala MF. Renal actions of dopexamine hydrochloride. Crit Inten Care 1990; 1: 163-74.
20. Angehn W, Schmid E, Aldlaus F, Niedermann K, Rothlin M. Effect of dopamine on hepatosplanchnic blood flow. J Cardiovasc Pharmacol 1980; 2: 257-65.
21. Angehn W, Schmid E, Althaus F, Niedermann K, Rothlin M. Leberdurchbulutung unter dopamin. Schweiz med Wscher 1977; 107: 1593-94.
22. Schmid E, Angehn W, Althaus F, Gattiker R, Rothlin M. The effect of dopamine on hepatic splanchnic blood low after open heart surgery in man. Intens Care Med 1979; 5: 183-88.
23. Peschl L. Klinische und experimentelle untersuchungen uber die wirkung von dopamin auf die hamodynamik und funktion von niere und leber. Wien Klin Wochenschr 1978; 90 (suppl 86): 3-33.
24. Smith G, O'Connor SE. An introduction to the pharmacological properties of dopacard (dopexamine hydrochloride). Am J Cardiol 1988; 62: 9c-17c.
25. Biro GP, Douglas JR, Keon WJ, Taichman GC. Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anaesthetized dogs. Am J Cardiol 1988; 26: 30c-36c.
26. Young Y, Baldock G. Gastric intramural pH, mixed venous lactate and dopexamine infusion. Clin Intens Care 1990; 2 (suppl 3): 2-5.
27. Leier CV. Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 1988; 62: 86E-93E.
28. Mitchell IM, Pollock JCS, Jamieson MPG. The validation of auricular densitometery for indocyanine green clearance measurement of hepatic blood flow during and after cardiopulmonary bypass in children. Perfusion 1995; 10: 197-208.
29. Cheerick GR, Stein SW, Leevy CM, Davidson CS. Indocyanine green: observations on its physical properties, plasma decay and hepatic extraction. J Clin Invest 1960; 39: 592-600.
30. Wheeler HO, Cranston WI, Meltzer JI. Hepatic uptake and billary extraction of indocyanine green in dogs. Proc Soc Exp Biol Med 1958; 99: 11-14.
31. Mathie RT, Desai JB, Taylor KM. The effect of normothermic bypass on hepatic blood flow in the dog. Perfusion 1986; 1: 245-53.
32. Shimokawa S. Portal and hepatic circulation during cardiopulmonary bypass in chronic the chronically congested liver; an experimental study. Nippon Geka Zasshi 1989; 90: 695-704.
33. Wood EH, Swan HJC, Helmholz JF Jr. Recording and basic patterns of dilution curves: normal and abnormal. Proc Staff Meet Mayo Clin 1957; 32: 464-77.
34. Gabe I, Shillingford J. The photo-electric ear piece technique for recording dye dilution curves. Br Heart J 1961; 23: 271-80.
35. Sutterer WF, Wood EH. A compensated dichromatic densitometer for indocyanine green. IRE Trans Biomed Elec 1962; 9: 133-37.
36. Leevy CM, Smith F, Longueville J, Paumgartner G, Howard MM. Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometery. J Am Med Assoc 1967; 200: 236-40.
37. Pawlik W, Mailman D, Shanbour LL, Jacobson ED. Dopamine effects on the intestinal circulation. Am Heart J 1976; 91: 325-31.
38. Yeh Bk, McNay JL, Goldberg LI. Attenuation of dopamine renal and mesenteric vasodilatation by haloperidol: evidence for a specific receptor. J Pharm Therap 1969; 168: 303-309.
39. Shanbour LL, Parker D. Effects of dopamine on the splanchnic circulation. Can J Physiol Pharmacol 1972; 50: 594-602.
40. Higgins CB, Millard RW, Braunwald E, Vatner SF. Effects and mechanisms of action on regional haemodynamics in the conscious dog. Am J Physiol 1973; 225: 432-37.
41. Priebe JH, Noldge GF, Armbuster K, Gieger K. Differential effects of dopexamine, dopamine and noradrenaline on splanchnic haemodynamics and oxygenation in the pig. Acta Anaesthiol Scand 1995; 39: 1088-96.
42. Kinoshita G, Washizu M, Murata N et al. The selective effects of dopamine and dobutamine on liver circulation in the dog. J Vet Med Sci 1995; 57: 293-97.
43. Leier CV, Heban PT, Huss P, Bush CA, Lewis RP. Comparative systemic and regional effects of dobutamine and dopamine in patients with congestive cardiac failure. Circulation 1978; 58: 466-75.
44. Cain SM, Curtis SE. Systemic and regional oxygen uptake and delivery and lactate flux in endotoxic dogs infused with dopexamine. Crit Care Med 1991; 19: 1552-60.
45. Smithies M, Yee TH, Jackson L, Bihari D. Protecting the gut and the liver in the critically ill: effects of dopexamine. Crit Care Med 1994; 22: 789-95.
46. Boyd R, Grouds M, Bennett DE. Randomized clinical trial of the deliberate perioperative increase of oxygen delivery on mortality in high risk surgical patients. J Am Med Assoc 1993; 270: 2699-707.
47. Golberg LI. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharm Rev 1972; 24: 1-29.
48. Gray PA, Bodenham AR, Park GR. A comparison of dopexamine and dopamine to prevent renal impairment in patients undergoing orthotopic liver transplantation. Anaesthesia 1991; 46: 638-41.
49. Rajfer SJ, Goldberg LI Dopamine in the treatment of heart failure. Eur Heart J 1983; 3 (suppl D): 103-106.
50. Makabali C, Weil MH, Henning RJ Dopamine and other sympathomimetics drugs for the treatment of low out put cardiac failure. Semin Anaesth 1982; 1: 63-69.